Home > Signal Pathway > AMQUAR单克隆抗体抑制剂 > AMQUAR 单克隆抗体抑制剂

AMQUAR 单克隆抗体抑制剂


  • Palivizumab MA1035

    Palivizumab, a humanized murine monoclonal antibody, is the only prophylactic agent approved for respiratory syncytial virus (RSV).

    More

  • Panitumumab MA1036

    Panitumumab, a fully human and less immunogenic anti-EGFR monoclonal antibody, is widely used in patients with metastatic colorectal cancer.

    More

  • Pertuzumab MA1037

    Pertuzumab, a monoclonal antibody against ERBB2 (HER2), is used in the treatment of HER2 positive breast cancer.

    More

  • Ranibizumab MA1038

    Ranibizumab, a humanized, affinity-matured VEGF antibody fragment that neutralizes all isoforms of VEGF, is approved for use in ophthalmology.

    More

  • Rituximab MA1039

    Rituximab, a monoclonal antibody directed at CD20 positive B-lymphocytes, is the first-line treatment of acquired thrombotic thrombocytopenic purpura.

    More
    • Current page3, Total Pages9, Total Record41 First Prev 12345 Next Last Goto
More